Anticancer compounds
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 20, 2023
Grant Date -
Dec 8, 2022
app pub date -
Jun 30, 2021
filing date -
Apr 20, 2017
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
The present invention discloses compounds for inhibition of uncontrolled cell proliferation particularly in cancer stem cells. Particularly, the invention relates to compounds of Formula III to XIV for the treatment of cancer, such as breast and prostate cancer.
First Claim
Other Claims data not available
Family
Loading Family data...
International Classification(s)
- 2021 Application Filing Year
- C07H Class
- 663 Applications Filed
- 288 Patents Issued To-Date
- 43.44 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- C07H Class
- 0 % this patent is cited more than
- 2 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Dec 20, 2026 |
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Dec 20, 2030 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Dec 20, 2034 |
